Reuters logo
BRIEF-Bayer says Japan approves Stivarga drug for colorectal cancer
March 25, 2013 / 8:21 AM / 4 years ago

BRIEF-Bayer says Japan approves Stivarga drug for colorectal cancer

FRANKFURT, March 25 (Reuters) - Bayer AG : * Says ministry of health, labor and welfare (mhlw) in Japan has approved

stivarga * Says approval of stivarga is for treatment of patients with unresectable,

advanced/recurrent colorectal cancer

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below